DNA damage-dependent apoptosis

Apoptosis, Cell Signaling, and Human Diseases

Volumn 2, Issue , 2007, Pages 263-272

  Skorski, Tomasz ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; checkpoint; DNA damage; DNA repair; mismatch; p53; p73

Indexed keywords

EID: 84888633040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-199-4_12     Document Type: Chapter

References (50)

1. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411:366-374.
2. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-254.
3. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 1999;18:7883-7899.
4. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-439.
5. Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest 1999;104:1645-1653.
6. Bracey TS, Williams AC, Paraskeva C. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 1997;3:1371-1381.
7. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999;401:616-620.
8. Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274:1664-1672.
9. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-168.
10. Abraham RT Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001;15:2177-2196.
11. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003;13:49-58.
12. Goldberg Z, Vogt Sionov R, Berger M, et al. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. Embo J 2002;21:3715-3727.
13. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387:296-299.
14. Schuler M, Green DR. Transcription, apoptosis and p53: catch-22. Trends Genet 2005; 21:182-187.
15. Nie Y, Li HH, Bula CM, Liu X. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization. Mol Cell Biol 2000;20:741-748.
16. Goga A, Liu X, Hambuch TM, et al. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 1995;11:791-799.
17. Norbury CJ, Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 2004;23: 2797-2808.
18. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994;54:3131-3135.
19. Slee EA, O'Connor DJ, Lu X. To die or not to die: how does p53 decide? Oncogene 2004; 23:2809-2818.
20. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11:577-590.
21. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 2004;24:6728-6741.
22. Deverman BE, Cook BL, Manson SR, et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 2002;111:51-62.
23. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994;370:220-223.
24. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-819.
25. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2:305-316.
26. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90-95.
27. Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999;399:806-809.
28. Agami R, Blandino G, Oren M, Shaul Y Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 1999;399:809-813.
29. Yuan ZM, Shioya H, Ishiko T, et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 1999;399:814-817.
30. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560-564.
31. Meyers M, Hwang A, Wagner MW, Boothman DA. Role of DNA mismatch repair in apoptotic responses to therapeutic agents. Environ Mol Mutagen 2004;44:249-264.
32. Stojic L, Brun R, Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst) 2004;3:1091-1101.
33. Fedier A, Fink D. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review). Int J Oncol 2004;24:1039-1047.
34. Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res 1999;59:3021-3027.
35. Bellacosa A, Cicchillitti L, Schepis F, et al. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA 1999;96:3969-3974.
36. Duckett DR, Bronstein SM, Taya Y, Modrich P. hMutSalpha-and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc Natl Acad Sci USA 1999;96:12, 384-12, 388.
37. Luo Y, Lin FT, Lin WC. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Mol Cell Biol 2004;24:6430-6444.
38. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA 2003;100:2420-2425. Epub 2003 Feb 24.
39. Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death Differ 2004;11:137-142.
40. Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000;462:83-100.
41. Fishel R. Signaling mismatch repair in cancer. Nat Med 1999;5:1239-1241.
42. Kolodner RD, Marsischky GT Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999;9:89-96.
43. Norbury CJ, Hickson ID. Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001;41:367-401.
44. Mailand N, Falck J, Lukas C, et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000;288:1425-1429.
45. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001;410:842-847.
46. Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000;14:1584-1588.
47. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20: 1803-1815.
48. Shah JV, Cleveland DW. Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 2000;103:997-1000.
49. Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000;256:50-57.
50. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911.